Genmab A/S

ISIN DK0010272202

 | 

WKN 565131

Market cap (in EUR)
15,665 m
Country
Denmark
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Quote

Description

Genmab A/S is an international biotechnology company, which engages in the development of human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline includes daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma, teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease, and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia. The company was founded by Donald Lee Drakeman, Florian Schonharting, and Jan G. J. van de Winkel on June 11, 1998, and is headquartered in Copenhagen, Denmark.
Show more Show less
Healthcare Biopharmaceuticals Non-System-Specific Biopharmaceuticals Denmark

Chart

Financials

Key metrics

Market capitalisation, EUR 15,665 m
EPS, EUR 11.56
P/B ratio 3.1
P/E ratio 21.8
Dividend yield 0.00%

Income statement (2025)

Revenue, EUR 3,303 m
Net income, EUR 855 m
Profit margin 25.89%

What ETF is Genmab A/S in?

There are 48 ETFs which contain Genmab A/S. All of these ETFs are listed in the table below. The ETF with the largest weighting of Genmab A/S is the Xtrackers MSCI Nordic UCITS ETF 1D.
ETF Weight Investment focus Fund size (in m EUR)
UBS Core MSCI World UCITS ETF USD acc 0.02%
Equity
World
10,350
iShares MSCI World UCITS ETF (Dist) 0.02%
Equity
World
8,301
Vanguard LifeStrategy 80% Equity UCITS ETF Accumulating 0.03%
Equity
World
Multi-Asset Strategy
1,214
iShares MSCI World Health Care Sector Advanced UCITS ETF USD (Dist) 0.18%
Equity
World
Health Care
Social/Environmental
560
Xtrackers MSCI Europe UCITS ETF 1D 0.11%
Equity
Europe
487
Vanguard LifeStrategy 20% Equity UCITS ETF Distributing 0.01%
Equity
World
Multi-Asset Strategy
15
VanEck Multi-Asset Conservative Allocation UCITS ETF 0.19%
Equity
World
Social/Environmental
Multi-Asset Strategy
21
Vanguard LifeStrategy 60% Equity UCITS ETF Accumulating 0.02%
Equity
World
Multi-Asset Strategy
940
Xtrackers MSCI World UCITS ETF 1D 0.02%
Equity
World
4,902
Vanguard FTSE All-World UCITS ETF (USD) Accumulating 0.02%
Equity
World
47,509
iShares Edge MSCI Europe Minimum Volatility UCITS ETF EUR (Dist) 0.27%
Equity
Europe
Low Volatility/Risk Weighted
24
Goldman Sachs Paris-Aligned Climate World Equity UCITS ETF USD (Acc) 0.05%
Equity
World
Social/Environmental
Climate Change
8
UBS MSCI World Socially Responsible UCITS ETF USD dis 0.08%
Equity
World
Social/Environmental
Climate Change
4,284
Vanguard ESG Developed Europe All Cap UCITS ETF (EUR) Distributing 0.15%
Equity
Europe
Social/Environmental
35
UBS Core MSCI World UCITS ETF USD dis 0.02%
Equity
World
2,026
iShares MSCI World Screened UCITS ETF USD (Dist) 0.02%
Equity
World
Social/Environmental
1,090
iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Dist) 0.01%
Equity
World
Social/Environmental
Climate Change
189
Vanguard FTSE Developed World UCITS ETF Acc 0.02%
Equity
World
5,870
Amundi Core MSCI Europe UCITS ETF Dist 0.12%
Equity
Europe
459
Vanguard FTSE Developed Europe UCITS ETF (EUR) Accumulating 0.11%
Equity
Europe
2,952
UBS Core MSCI World UCITS ETF hGBP dis 0.02%
Equity
World
152
Vanguard LifeStrategy 40% Equity UCITS ETF Distributing 0.01%
Equity
World
Multi-Asset Strategy
45
Vanguard FTSE All-World UCITS ETF (USD) Distributing 0.02%
Equity
World
23,299
iShares MSCI Europe Screened UCITS ETF EUR (Dist) 0.13%
Equity
Europe
Social/Environmental
504
iShares MSCI ACWI UCITS ETF USD (Acc) 0.02%
Equity
World
30,645
Vanguard LifeStrategy 80% Equity UCITS ETF Distributing 0.03%
Equity
World
Multi-Asset Strategy
93
Vanguard LifeStrategy 40% Equity UCITS ETF Accumulating 0.01%
Equity
World
Multi-Asset Strategy
241
iShares STOXX Europe 600 Health Care UCITS ETF (DE) 0.90%
Equity
Europe
Health Care
708
iShares Core MSCI Europe UCITS ETF EUR (Dist) 0.11%
Equity
Europe
10,832
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.02%
Equity
World
Social/Environmental
604
HSBC Europe Ex UK Screened Equity UCITS ETF EUR (Dist) 0.24%
Equity
Europe
Social/Environmental
Climate Change
46
UBS Core MSCI World UCITS ETF hEUR acc 0.02%
Equity
World
1,086
Vanguard FTSE Developed Europe ex UK UCITS ETF (EUR) Distributing 0.14%
Equity
Europe
3,369
iShares MSCI Europe Paris-Aligned Climate UCITS ETF EUR (Dist) 0.03%
Equity
Europe
Social/Environmental
Climate Change
27
Amundi Prime Europe UCITS ETF DR (D) 0.13%
Equity
Europe
258
iShares STOXX Europe Equity Multifactor UCITS ETF EUR (Dist) 0.01%
Equity
Europe
Multi-Factor Strategy
219
iShares MSCI Europe CTB Enhanced ESG UCITS ETF EUR (Dist) 0.03%
Equity
Europe
Social/Environmental
4,980
Vanguard FTSE Developed World UCITS ETF Distributing 0.02%
Equity
World
4,185
Amundi MSCI Europe Growth UCITS ETF Dist 0.24%
Equity
Europe
Growth
92
Vanguard FTSE Developed Europe UCITS ETF Distributing 0.11%
Equity
Europe
4,844
iShares MSCI World CTB Enhanced ESG UCITS ETF USD (Dist) 0.00%
Equity
World
Social/Environmental
631
Xtrackers MSCI Nordic UCITS ETF 1D 1.02%
Equity
Europe
1,043
Vanguard FTSE Developed Europe ex UK UCITS ETF (EUR) Accumulating 0.14%
Equity
Europe
1,464
Amundi MSCI Europe UCITS ETF Acc 0.11%
Equity
Europe
622
iShares MSCI Europe ex-UK UCITS ETF 0.14%
Equity
Europe
1,770
Amundi MSCI Europe SRI Climate Paris Aligned UCITS ETF Dist 0.70%
Equity
Europe
Social/Environmental
44
Vanguard LifeStrategy 60% Equity UCITS ETF Distributing 0.02%
Equity
World
Multi-Asset Strategy
122
Vanguard LifeStrategy 20% Equity UCITS ETF Accumulating 0.01%
Equity
World
Multi-Asset Strategy
102

Performance

Returns overview

YTD -7.12%
1 month +1.50%
3 months +8.38%
6 months -3.26%
1 year +32.15%
3 years -25.48%
5 years -36.12%
Since inception (MAX) +68.79%
2025 +35.95%
2024 -30.38%
2023 -27.16%
2022 +12.59%

Monthly returns in a heat map

Risk

Risk metrics in this section:
 
  • Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
  • Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
  • Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
ETF returns include dividend payments (if applicable).
Show more Show less

Risk overview

Volatility 1 year 32.44%
Volatility 3 years 31.37%
Volatility 5 years 30.91%
Return per risk 1 year 0.99
Return per risk 3 years -0.30
Return per risk 5 years -0.28
Maximum drawdown 1 year -32.19%
Maximum drawdown 3 years -54.64%
Maximum drawdown 5 years -63.32%
Maximum drawdown since inception -63.32%

Rolling 1 year volatility

— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.